Fiscal 2022 Universal Registration Document

6.5.2 Information on the components of compensation paid or awarded to Corporate Officers

6.5.2.1 Compensation of Sophie Bellon, Chairwoman and Chief Executive Officer

The following tables show a breakdown of the various components of Sophie Bellon’s compensation.

The components of the compensation for the role of Chairwoman of the Board of Directors until September 30, 2021, then for the role of Chairwoman of the Board of Directors and interim Chief Executive Officer from October 1, 2021 to February 28, 2022, were established in line with the compensation policy for the Chairwoman of the Board of Directors approved by the shareholders at the Combined Annual Shareholders Meeting of December 14, 2021 (twelfth resolution). This policy provides for fixed compensation, collective health and benefit plans as well as benefits in kind. It does not include any other variable or exceptional compensation, long-term compensation or director’compensation.

The components of the compensation for the role of Chairwoman and Chief Executive Officer from March 1, 2022 were established in line with the compensation policy for the Chief Executive Officer approved by the shareholders at the Combined Annual Shareholders Meeting of December 14, 2021 (thirteenth resolution). This policy provides for fixed, variable and long-term compensation, a supplemental pension plan, collective health and benefit plans as well as benefits in kind. It does not include any multi-year variable compensation, exceptional compensation or any other post-term benefit.

At the Ordinary Annual Shareholders Meeting of December 19, 2022, shareholders will be given a “say-on-pay” vote on the total compensation and benefits paid during or awarded for Fiscal 2022 to Sophie Bellon for her duties performed during the fiscal year.

Summary of compensation, stock options and performance shares awarded to the Chairwoman of the Board, then Chairwoman and Chief Executive Officer

TABLE 1, BASED ON THE AFEP-MEDEF CODE TEMPLATE AND AMF RECOMMENDATION 2021-02

Download the table